Share Issue News

Discover the latest share issue news. Stay informed about new share offerings, market impacts, investor reactions, and financial strategies. Get updates on how share issues influence company valuations and investment opportunities.

Apr 17, 2026 at 4:05 PM

Savara Announces New Employment Inducement Grant

LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to new employees. On April 14, 2026, the Compensation Committee of Savara's Board of Directors granted the inducement awards to 24 new employees who recently joined the Company. The inducement awards consist of options to purchase 18,500 shares of the Company’s common stock, restricted stock units (RSUs) cove...
Apr 17, 2026 at 4:00 PM

Eaton Vance Limited Duration Income Fund, Eaton Vance Senior Floating-Rate Trust, and Eaton Vance Senior Income Trust Announce Tender Offers for Outstanding Auction Preferred Shares

BOSTON--(BUSINESS WIRE)--Eaton Vance Limited Duration Income Fund (NYSE: EVV), Eaton Vance Senior Floating-Rate Trust (NYSE: EFR), and Eaton Vance Senior Income Trust (NYSE: EVF) (each a “Fund,” and together, the “Funds”) announced that the Board of Trustees of each Fund has authorized each Fund to conduct a voluntary tender offer for up to 100% of its outstanding auction preferred shares (“APS”) at a price per share equal to 98% of the APS liquidation preference of $25,000 per share (or $24,50...
Apr 16, 2026 at 8:00 PM

Enveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that it has entered into definitive agreements for the purchase and sale of 2,222,223 shares of its common stock (or pre-funded warrants in lieu thereof), Series I warrants to purchase up to an aggregate of 2,222,223 shares of common stock a...
Apr 16, 2026 at 4:01 PM

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that, effective on April 15, 2026, it granted stock options to purchase an aggregate of 129,565 shares of common stock to fourt...
Apr 16, 2026 at 2:30 PM

Aris Mining Announces Revisions to Equity Compensation Plan Ahead of Annual General Meeting

VANCOUVER, British Columbia--(BUSINESS WIRE)--Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS; NYSE: ARIS) announced today that, based on further review of its proposed equity compensation plans, it has decided to revise those plans ahead of the Company’s upcoming annual general meeting of shareholders to be held on May 7, 2026 (the AGM). The Company determined that the initially proposed share reserves were greater than required and has reduced the proposed share reserve caps f...
Apr 16, 2026 at 10:16 AM

NMG Announces Closing of US$96.5 Million Equity Public Offering

MONTRÉAL--(BUSINESS WIRE)--As part of the financing package for the phased development of the commercial operations of its Matawinie Mine (“Phase-2 Matawinie Mine”), Nouveau Monde Graphite Inc. (“NMG” or the “Company”) (NYSE: NMG, TSX: NOU) closed today its previously announced bought deal public offering of 52,440,000 subscription receipts (the “Subscription Receipts”), which includes the exercise in full of the over-allotment option, at a price of US$1.84 per Subscription Receipt, for gross p...
Apr 15, 2026 at 8:00 PM

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on April 14, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 20,000 shares of common stock to a...
Apr 15, 2026 at 6:00 PM

Insight Enterprises Grants New CEO Jack Azagury Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

CHANDLER, Ariz.--(BUSINESS WIRE)--Insight Enterprises (NASDAQ: NSIT) today announced that an inducement equity award has been granted to its new President and Chief Executive Officer, Jack Azagury, on April 15, 2026 (the "Grant Date"). The equity award is consistent with the previously disclosed terms of Mr. Azagury’s offer letter and was approved by the Compensation Committee of the Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4). Insight is issuing this press release purs...
Apr 15, 2026 at 12:00 PM

Getlink SE: Information Relating to the Total Number of Shares and Voting Rights Which Form the Share Capital

PARIS--(BUSINESS WIRE)--Regulatory News: Getlink SE (Paris: GET) Presenter / Corporate Name : Getlink SE - Société Européenne, RCS Paris 483 385 142 37-39 rue de la Bienfaisance, 75008 Paris Date Number of ordinary shares in issue (1) Number of voting rights Theoretical (2) (3) Exercisable (4) 13 April 2026 550,000,000 642,638,842 634,673,889 * * * * (1) The share capital is divided into 550,000,000 ordinary shares of a nominal value of €0.40. (2) In accordance with Article 223-11 of the AMF Ge...
Apr 15, 2026 at 8:00 AM

Mountain Valley MD Announces Closing of Non-Brokered Private Placement of Units and Concurrent Shares for Debt Transactions

TORONTO--(BUSINESS WIRE)--Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTC: MVMDF) announces that it has closed its previously announced non-brokered private placement offering of units for aggregate gross proceeds of CAD $2,000,000 (the “Offering”) and, concurrently, two shares for debt transactions (each, a “Shares for Debt Transaction”, collectively the “Shares for Debt Transactions”), in each case as described below. All aspects of the Offering and the Shares for...
Turn Your News Into Headlines!
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up